ImmunityBio, Inc. , a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement with Japan BCG Laboratory ("JBL"), the Tokyo-based developer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results